U.S. Pays More for Drugs than Other Nations, would Negotiate Down with Medicare for All

U.S. Pays More for Drugs than Other Nations, would Negotiate Down with Medicare for All “U.S. payers are currently charged substantially more for drugs than payers in other countries (Danzon and Furukawa, 2008), which may be partially attributable to the fact that Medicare is currently barred from negotiating drug prices on behalf of enrollees. Within […]

Continue reading